Stretton Serina
ProScribe-Envision Pharma Group, Sydney, New South Wales, Australia.
BMJ Open. 2014 Jul 14;4(7):e004777. doi: 10.1136/bmjopen-2013-004777.
Ghostwriting of industry-sponsored articles is unethical and is perceived to be common practice.
To systematically review how evidence for the prevalence of ghostwriting is reported in the medical literature.
MEDLINE via PubMed 1966+, EMBASE 1966+, The Cochrane Library 1988+, Medical Writing 1998+, The American Medical Writers Association (AMWA) Journal 1986+, Council of Science Editors Annual Meetings 2007+, and the Peer Review Congress 1994+ were searched electronically (23 May 2013) using the search terms ghostwrit*, ghostauthor*, ghost AND writ*, ghost AND author*.
All publication types were considered; only publications reporting a numerical estimate of possible ghostwriting prevalence were included.
Two independent reviewers screened the publications; discrepancies were resolved by consensus. Data to be collected included a numerical estimate of the prevalence of possible ghostwriting (primary outcome measure), definitions of ghostwriting reported, source of the reported prevalence, publication type and year, study design and sample population.
Of the 848 publications retrieved and screened for eligibility, 48 reported numerical estimates for the prevalence of possible ghostwriting. Sixteen primary publications reported findings from cross-sectional surveys or descriptive analyses of published articles; 32 secondary publications cited published or unpublished evidence. Estimates on the prevalence of possible ghostwriting in primary and secondary publications varied markedly. Primary estimates were not suitable for meta-analysis because of the various definitions of ghostwriting used, study designs and types of populations or samples. Secondary estimates were not always reported or cited correctly or appropriately.
Evidence for the prevalence of ghostwriting in the medical literature is limited and can be outdated, misleading or mistaken. Researchers should not inflate estimates using non-standard definitions of ghostwriting nor conflate ghostwriting with other unethical authorship practices. Editors and peer reviewers should not accept articles that incorrectly cite or interpret primary publications that report the prevalence of ghostwriting.
由行业资助撰写文章的代笔行为是不道德的,且被视为常见做法。
系统评价医学文献中关于代笔行为流行程度的证据是如何报道的。
通过电子检索(2013年5月23日)了1966年及以后的MEDLINE via PubMed、1966年及以后的EMBASE、1988年及以后的Cochrane图书馆、1998年及以后的《医学写作》、1986年及以后的《美国医学撰写人协会杂志》、2007年及以后的科学编辑理事会年会以及1994年及以后的同行评审大会,检索词为ghostwrit*、ghostauthor*、ghost AND writ*、ghost AND author*。
考虑所有出版类型;仅纳入报告代笔行为可能流行程度数值估计的出版物。
两名独立评审员筛选出版物;分歧通过协商解决。要收集的数据包括代笔行为可能流行程度的数值估计(主要结局指标)、所报道的代笔行为定义、所报道流行程度的来源、出版类型和年份、研究设计和样本人群。
在检索并筛选资格的848篇出版物中,48篇报告了代笔行为可能流行程度的数值估计。16篇主要出版物报告了对已发表文章的横断面调查或描述性分析结果;32篇次要出版物引用了已发表或未发表的证据。主要和次要出版物中代笔行为可能流行程度的估计差异显著。由于所使用的代笔行为定义、研究设计以及人群或样本类型各异,主要估计值不适合进行荟萃分析。次要估计值并非总是被正确或恰当地报道或引用。
医学文献中代笔行为流行程度的证据有限,可能过时、具有误导性或存在错误。研究人员不应使用非标准的代笔行为定义夸大估计值,也不应将代笔行为与其他不道德的作者身份行为混为一谈。编辑和同行评审人员不应接受错误引用或解释报告代笔行为流行程度的主要出版物的文章。